Amoxicillin-Clavulanate: Effects on Gut Health and Digestion

Amoxicillin-clavulanate is one of the most widely prescribed antibiotics in the world, and it is also one of the roughest on your digestive system. Roughly one in five people who take it develop antibiotic-associated diarrhea, a rate more than double that of amoxicillin alone. The clavulanate component, added to overcome bacterial resistance, is largely responsible for the extra gut trouble. Beyond simple diarrhea, the drug reshapes the community of bacteria living in your intestines, alters fungal populations, and can leave traces in your microbiome weeks or months after the last pill.

Why Diarrhea Is So Common With This Antibiotic

Clavulanic acid was paired with amoxicillin for a good reason. Many bacteria produce enzymes called beta-lactamases that chew up penicillin-type antibiotics before they can work. Clavulanic acid blocks those enzymes, making amoxicillin effective against a much wider range of infections.¹ But that broader killing power comes at a cost: it wipes out more of the harmless bacteria in your gut, and clavulanate itself appears to directly irritate the intestinal tract.

A pooled analysis of pediatric trials put the diarrhea rate at about 20% for amoxicillin-clavulanate, compared with roughly 8% for amoxicillin alone and just over 1% for penicillin V.² That tenfold gap between amoxicillin-clavulanate and basic penicillin is striking, and it tracks with adult experience too. The clavulanate component is so strongly linked to gastrointestinal side effects that it actually limits how much amoxicillin can be packed into each dose.³

Part of what makes the diarrhea so reliable is a motility effect. Research on children given amoxicillin-clavulanate directly into the small intestine found that the drug triggered powerful contractions in the duodenum, the kind of rhythmic squeezing normally seen only during fasting. The researchers noted the effect was strong enough that amoxicillin-clavulanate could theoretically be used as a gut-motility drug.⁴ In practical terms, the antibiotic speeds up transit through your intestines, which means less water gets absorbed and stools become looser. This happens on top of the bacterial die-off that independently causes diarrhea, so the two mechanisms stack.

What Happens to Your Gut Bacteria

Your gut is home to hundreds of bacterial species, and amoxicillin-clavulanate reshuffles that community in predictable ways. A randomized trial in healthy volunteers tracked microbiome changes during and after a standard course. While on the antibiotic, participants lost populations of Roseburia, a genus that produces butyrate, a short-chain fatty acid important for colon health. At the same time, Escherichia, Parabacteroides, and Enterobacter bloomed.⁵ The pattern is a common one for broad-spectrum antibiotics: beneficial, oxygen-sensitive anaerobes get hammered while hardier, often less desirable, bacteria fill the vacuum.

Clavulanic acid does more than just shield amoxicillin from beta-lactamases. It also binds directly to structural proteins in certain bacteria, which may explain why the combination drug has such an outsized effect on the microbiome compared with amoxicillin alone.⁶ In other words, clavulanate is not a perfectly passive sidekick. It has its own antibacterial properties that widen the collateral damage.

The Clostridioides difficile Risk

Among the more serious gut-related concerns with any antibiotic is the risk of C. difficile infection, a bacterium that thrives when normal gut flora are suppressed and can cause severe, sometimes life-threatening diarrhea. Amoxicillin-clavulanate carries a meaningfully elevated risk. A large hospital-based study found that exposure to the drug was associated with about a 72% higher hazard of developing C. difficile infection, and each additional day of treatment raised the hazard by another 15%.⁷

The community-acquired picture is even more dramatic in relative terms. A case-control study found that amoxicillin-clavulanate carried a risk of community-associated C. difficile infection comparable to later-generation cephalosporins, with an odds ratio over eight. That was more than four times the associated risk of amoxicillin without clavulanate.⁸ A pediatric study echoed this, showing a higher risk of C. difficile with amoxicillin-clavulanate than with amoxicillin alone for sinusitis, though the absolute number of cases was small.⁹

The practical implication is straightforward: if your infection would respond to amoxicillin alone, using the combination version adds C. difficile risk without clear benefit. This is one reason prescribing guidelines increasingly stress that amoxicillin-clavulanate should be reserved for infections where beta-lactamase-producing bacteria are likely involved, rather than used as a default first choice.

How Dose and Formulation Affect Your Gut

Not all amoxicillin-clavulanate prescriptions are the same. Formulations vary in how much clavulanate they contain and whether the amoxicillin is immediate-release or extended-release, and these differences affect how your gut responds. A randomized trial comparing standard-dose and high-dose formulations for sinusitis found that diarrhea was common in both groups by day three, but severe diarrhea was substantially more frequent with the high-dose immediate-release version, affecting about 16% of those patients compared with roughly 5% on the standard dose.¹⁰

Extended-release formulations are designed partly to address this. By spreading out absorption, they keep clavulanate from hitting the intestine in a concentrated bolus. Some pharmacies also carry formulations with a higher amoxicillin-to-clavulanate ratio, which delivers more of the antibiotic punch with less of the gut-irritating inhibitor. If you have had bad gastrointestinal reactions in the past, it is worth asking your doctor or pharmacist whether a different ratio or release formulation is available for your infection.

Recovery After a Course Ends

The good news is that for most people, the microbiome does bounce back. A systematic review of the most commonly prescribed antibiotics found that gut bacteria generally return to their baseline composition within a few weeks of stopping treatment, though some studies documented lingering effects for two to six months.¹¹ “Generally” and “most people” are doing heavy lifting in that sentence, though. The randomized trial in healthy volunteers mentioned earlier found that microbiota alterations were moving toward baseline two weeks after finishing amoxicillin-clavulanate but had not fully returned.⁵

For certain bacterial groups, the disruption appears to last longer. A study tracking Bifidobacterium populations after just a five-day course of amoxicillin-clavulanate found that the overall microbiota similarity to pre-treatment levels was still significantly reduced at one and two months. The total microbial profile had recovered to only about 55-62% similarity to its original state by that point.¹² Bifidobacteria are among the bacterial groups most strongly associated with digestive health and immune regulation, so their slow return may partly explain why some people feel “off” digestively for weeks after finishing the antibiotic.

Effects on Gut Fungi

Your gut does not just contain bacteria. It also harbors fungi, collectively called the mycobiome, and amoxicillin-clavulanate affects these populations in unexpected ways. While it has long been assumed that antibacterial drugs promote fungal overgrowth by removing bacterial competition, research in a mouse model found the opposite: amoxicillin-clavulanate actually decreased the total fungal population in the gut. At the same time, it triggered a complete remodeling of which fungi were present, with Aspergillus, Cladosporium, and Valsa genera becoming enriched while overall diversity dropped. This reduction in fungal load was unusual compared with other antibiotics, which tended to increase it.

The same study found that amoxicillin-clavulanate concurrently boosted Enterobacteriaceae among gut bacteria, suggesting the bacterial and fungal shifts are interconnected. When beneficial bacteria disappear, the ecological niches that fungi depend on shift too, leading to a different fungal landscape rather than simply more of everything. This is a relatively new area of research, and it is not yet clear what the downstream health consequences of fungal remodeling are in humans. But it does complicate the common advice to watch out for yeast infections while on antibiotics. Amoxicillin-clavulanate can increase vaginal or oral yeast infections, as one large pediatric study confirmed,⁹ but what it does to gut fungi appears to be a more nuanced story than simple overgrowth.

Antibiotic Resistance Genes Left Behind

Beyond changing which bacteria live in your gut, amoxicillin-clavulanate also changes what those bacteria can do. After a course of the drug, the surviving bacteria tend to carry more antibiotic resistance genes, particularly beta-lactamase genes, which is ironic given that the whole point of clavulanate is to defeat beta-lactamases in the target pathogen. The antibiotic effectively selects for gut bacteria that are resistant to it, enriching the so-called “resistome.”¹³

In one study, some participants showed clear increases in beta-lactam resistance gene abundance following amoxicillin-clavulanate treatment, accompanied by blooms in Proteobacteria. After autologous fecal microbiota transplant, where participants received their own pre-treatment stool back, conditions returned closer to pre-antibiotic levels.¹⁴ You are unlikely to be offered a fecal transplant after a routine antibiotic course, but the research illustrates an important point: the resistance genes that accumulate during treatment can persist in your gut for some time, potentially making future infections harder to treat with the same class of drugs.

Probiotics and Dietary Strategies

Given how reliably amoxicillin-clavulanate causes diarrhea, it is no surprise that many people reach for probiotics during or after a course. The evidence here is genuinely encouraging but not a slam dunk. Multiple randomized trials and meta-analyses have found that specific probiotic strains, particularly Lactobacillus-based and Saccharomyces boulardii products, reduce the incidence of antibiotic-associated diarrhea.¹⁵ The key word is “specific strains.” Not every yogurt or supplement on the shelf has been tested, and the benefits are strain-dependent. If you are going to use a probiotic alongside amoxicillin-clavulanate, look for products that name the strain, not just the genus, and that have been studied in the context of antibiotic use.

On the dietary side, early-stage research suggests that certain types of fiber may help the microbiome recover from amoxicillin-clavulanate disruption. In an experimental model simulating an infant gut, supplementation with a specific non-digestible carbohydrate promoted the return of Ruminococcus and other beneficial genera that the antibiotic had depleted.¹⁶ This is laboratory work and not yet a clinical recommendation, but it aligns with the broader principle that a fiber-rich diet feeds the beneficial anaerobic bacteria that antibiotics suppress. During and after a course of amoxicillin-clavulanate, leaning into whole grains, legumes, vegetables, and fermented foods is a reasonable strategy even if the specific science is still catching up.

Timing matters too. Taking the antibiotic at the start of a meal rather than on an empty stomach can reduce nausea and diarrhea for many people. The food slows gastric emptying, which means less clavulanate hitting the small intestine all at once. This is a practical trick that is easy to overlook but can make a real difference in tolerability.

Maternal and Early-Life Exposure

The effects of amoxicillin-clavulanate on the gut take on added significance in pregnancy and early infancy. A recent study in an animal model found that maternal treatment with amoxicillin-clavulanate, but not ampicillin alone, significantly reduced infants’ antibody responses to a pneumococcal vaccine at four and six weeks after initial immunization. The effect was transient, with immune markers normalizing by eight weeks, but the finding reveals a previously underappreciated route of antibiotic influence from mother to offspring.¹⁷

The mechanism appears to run through microbiome and metabolome disruption. Maternal amoxicillin-clavulanate altered bile acids, certain lipid classes, and indole derivatives in both mother and offspring, while key bacterial groups including Bacteroidales and Coriobacteriales were depleted.¹⁷ This does not mean pregnant or breastfeeding women should refuse the antibiotic when it is genuinely needed. It does suggest that the decision to prescribe amoxicillin-clavulanate rather than a narrower-spectrum alternative deserves extra thought in the perinatal period, especially given that the immune effects appear to be specific to the combination drug rather than to beta-lactam antibiotics in general.

The Liver-Gut Connection

Amoxicillin-clavulanate is the most common antibiotic cause of idiosyncratic drug-induced liver injury, a rare but well-documented side effect where the drug triggers unpredictable liver damage in susceptible individuals. What is increasingly clear is that this liver toxicity may not be entirely separate from its gut effects. Research into patients who developed liver injury after taking the drug found that they had distinct gut microbiota profiles compared with healthy controls, and these profiles were linked to particular patterns in bile acid metabolism and other fecal metabolites.¹⁸

The gut and the liver are connected by the portal vein, meaning everything absorbed from the intestine passes through the liver before reaching the rest of the body. When amoxicillin-clavulanate reshapes gut bacteria and their metabolic output, the chemical signals arriving at the liver change too. This is an active area of investigation, and researchers are exploring whether a person’s pre-existing microbiome composition could help predict who is at risk for liver injury. For now, the connection serves as a reminder that the drug’s effects on the gut are not confined to diarrhea and cramping. They ripple outward into other organ systems in ways that science is only beginning to map.

When the Combination Drug Is and Is Not Worth It

Amoxicillin-clavulanate exists because some infections genuinely require it. Bite wounds, certain urinary tract infections, chronic sinusitis with likely resistant organisms, and some skin infections involve bacteria that produce beta-lactamases, and amoxicillin alone would fail.¹ In those situations, the gut side effects are a worthwhile trade-off. The problem arises when the combination is prescribed for infections where amoxicillin alone, or even no antibiotic at all, would suffice. Ear infections, strep throat, and many cases of acute sinusitis fall into this category. When amoxicillin-clavulanate is used unnecessarily, you absorb all the extra gut disruption, the C. difficile risk, the resistome enrichment, and the prolonged microbiome disturbance without a corresponding benefit.

If your doctor prescribes amoxicillin-clavulanate and you have had bad gastrointestinal experiences with it before, it is reasonable to ask whether plain amoxicillin or another narrower-spectrum antibiotic could work for your specific infection. Clinicians are generally receptive to this conversation, especially given the growing emphasis on antibiotic stewardship. And if you do need the combination drug, taking it with food, using a strain-tested probiotic, maintaining a fiber-rich diet, and staying hydrated are all steps that can soften the impact on your gut while the antibiotic does its necessary work.